Site icon UGA Today

Targeted approach

Terns-H.Lab

Rebecca and Michael Terns

The knowledge that bacteria possess adaptable immune systems that protect them from individual viruses and other foreign invaders is relatively new to science, and researchers across the globe are working to learn how these systems function and to apply that knowledge in industry and medicine.

Now, a team of UGA researchers has discovered how to harness this bacterial immune system to selectively target and silence genes. The finding, published in the early online edition of the journal Molecular Cell, reveals a powerful new tool that has far-reaching implications for biotechnology and biomedical research.

“Scientists study bacteria and other microorganisms to understand essential life processes as well as to improve their use in the safe production of foods, biofuels and pharmaceuticals, and to fight those that cause disease,” said Michael Terns, a professor in the departments of biochemistry and molecular biology, and genetics in the Franklin College of Arts and Sciences. “And now we have a new way to engineer bacteria to decrease or even eliminate the expression of the genes of our choosing.”

The bacterial immune system consists of two components. The first is an RNA (a molecule that, like DNA, contains genetic information) that acts as a homing signal to target a virus or another cellular invader. The second component is a complex of proteins that cleaves the invader’s genetic material. In a 2009 paper published in the journal Cell, Terns, co-principal investigator Rebecca Terns and their colleagues were the first to describe how this pathway, known as the Cmr branch of the CRISPR-Cas immune system, works.

In their latest study, the researchers further their understanding of the system and use that in-depth knowledge to essentially hijack the bacterial immune system to direct its homing system to a target of their choosing. Using customized CRISPR RNAs with a modified homing signal, the scientists were able to destroy the message for a protein that is responsible for resistance to the most commonly prescribed family of antibiotics, the beta-lactam antibiotics (that includes, for example, amoxicillin).

“In this study we identified the key features of the RNAs that the system normally uses, and then showed that using this information we can program the system with engineered ‘homing’ RNAs to destroy new targets,” said Becky Terns, co-leader of the UGA team. “New targets would go beyond viruses and other invaders to include essentially any gene present in the organism being studied. And because we have defined the components of this system, it is possible that we can introduce it into organisms that do not already possess it to further expand the potential industrial and biomedical applications.”

Researchers could systematically shut down the function of individual genes, for example, to discern the role they play in essential cellular processes. Gene expression could be modified in bacteria that are used to break down plant materials for biofuels or that produce medications, such as insulin, to improve quality and production.

“By defining the key components of the system, Drs. Terns and their colleagues have set the stage for the development of a new tool for targeting specific RNA molecules in diverse cell types, potentially providing biomedical researchers with a valuable new way to analyze gene functions,” said Michael Bender, who oversees RNA processing and function grants at the National Institutes of Health’s National Institute of General Medical Sciences.

Exit mobile version